Indol-alanine derivatives as selective S1P4-agonists

Details for Australian Patent Application No. 2005206289 (hide)

Owner Novartis AG

Inventors Azzaoui, Kamal; Buehlmayer, Peter; Guerini, Danilo; Bouhelal, Rochdi; Koller, Manuel

Agent Davies Collison Cave

Pub. Number AU-B-2005206289

PCT Pub. Number WO2005/070886

Priority 0401332.2 21.01.04 GB

Filing date 20 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 4 December 2008

International Classifications

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070886 Priority application(s): WO2005/070886

4 December 2008 Application Accepted

  Published as AU-B-2005206289

2 April 2009 Standard Patent Sealed

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206290-Thiazole derivatives as A2b antagonists

2005206288-Organic compounds